Health

Q&A: The rising rates of immunosuppression among US adults

Early in the COVID-19 pandemic, as it became clear that people with suppressed immune systems were particularly vulnerable to the worst of the virus, public health officials prioritized their protection. Leaders presented ...

Medications

Who benefits from direct-to-consumer pharmaceutical advertising?

A new study co-authored by a University of Massachusetts Amherst economist reveals the value of government vaccine recommendations to drugmakers, as well as potential benefits of advertising pharmaceuticals directly to consumers—a ...

page 18 from 40